There is also evidence that GBM cells can transform MSCs by reducing their expression of miR-146a-5p, leading to overexpression of its target gene, heterogeneous nuclear ribonucleoprotein D (HNRNPD). This evidence concerns the gene HNRNPD and glioblastoma.